Hybrid Attentional Memory Network for Computational drug repositioning

• URL: http://arxiv.org/abs/2006.06910v2
• Date: Sun, 15 Nov 2020 13:50:17 GMT
• Title: Hybrid Attentional Memory Network for Computational drug repositioning
• Authors: Jieyue He and Xinxing Yang (Equal contributor) and Zhuo Gong and lbrahim Zamit
• Abstract summary: The cold start problem has always been a major challenge in the field of computational drug repositioning. We propose the Hybrid Attentional Memory Network (HAMN) model, a deep architecture combines two classes of CF model in a nonlinear manner. Our proposed HAMN model is superior to other comparison models according to the AUC, AUPR and HR indicators.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Drug repositioning is designed to discover new uses of known drugs, which is an important and efficient method of drug discovery. Researchers only use one certain type of Collaborative Filtering (CF) models for drug repositioning currently, like the neighborhood based approaches which are good at mining the local information contained in few strong drug-disease associations, or the latent factor based models which are effectively capture the global information shared by a majority of drug-disease associations. Few researchers have combined these two types of CF models to derive a hybrid model with the advantages of both of them. Besides, the cold start problem has always been a major challenge in the field of computational drug repositioning, which restricts the inference ability of relevant models. Inspired by the memory network, we propose the Hybrid Attentional Memory Network (HAMN) model, a deep architecture combines two classes of CF model in a nonlinear manner. Firstly, the memory unit and the attention mechanism are combined to generate the neighborhood contribution representation to capture the local structure of few strong drug-disease associations. Then a variant version of the autoencoder is used to extract the latent factor of drugs and diseases to capture the overall information shared by a majority of drug-disease associations. In that process, ancillary information of drugs and diseases can help to alleviate the cold start problem. Finally, in the prediction stage, the neighborhood contribution representation is combined with the drug latent factor and disease latent factor to produce the predicted value. Comprehensive experimental results on two real data sets show that our proposed HAMN model is superior to other comparison models according to the AUC, AUPR and HR indicators.

Related papers

• Boosting drug-disease association prediction for drug repositioning via dual-feature extraction and cross-dual-domain decoding [9.721502993958193]
  We propose a Dual-Feature Drug Repositioning Neural Network (DFDRNN) model to represent drugs and diseases. Our proposed DFDRNN model outperforms six state-of-the-art methods on four benchmark datasets. Case studies on two diseases show that the proposed DFDRNN model can be applied in real-world scenarios.
  arXiv  Detail & Related papers  (2024-07-16T15:02:18Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Hierarchical Graph Representation Learning for the Prediction of Drug-Target Binding Affinity [7.023929372010717]
  We propose a novel hierarchical graph representation learning model for the drug-target binding affinity prediction, namely HGRL-DTA. In this paper, we adopt a message broadcasting mechanism to integrate the hierarchical representations learned from the global-level affinity graph and the local-level molecular graph. Besides, we design a similarity-based embedding map to solve the cold start problem of inferring representations for unseen drugs and targets.
  arXiv  Detail & Related papers  (2022-03-22T04:50:16Z)
• MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy [2.446672595462589]
  We propose a multimodal graph neural network that can predict the synergistic effect of drug combinations for cancer treatment. Our model captures the representation based on the context of drugs at multiple scales based on a drug-protein interaction network and metadata. We demonstrate that the model makes high-quality predictions over a wide range of cancer cell line tissues.
  arXiv  Detail & Related papers  (2021-10-28T13:10:25Z)
• The Neural Metric Factorization for Computational Drug Repositioning [1.5206182560183663]
  computational drug repositioning aims to discover new therapeutic diseases for marketed drugs. The matrix factorization model has become a mainstream cornerstone technique for computational drug repositioning. We propose a neural metric factorization model for computational drug repositioning.
  arXiv  Detail & Related papers  (2021-09-16T03:14:43Z)
• A Twin Neural Model for Uplift [59.38563723706796]
  Uplift is a particular case of conditional treatment effect modeling. We propose a new loss function defined by leveraging a connection with the Bayesian interpretation of the relative risk. We show our proposed method is competitive with the state-of-the-art in simulation setting and on real data from large scale randomized experiments.
  arXiv  Detail & Related papers  (2021-05-11T16:02:39Z)
• Adversarial Sample Enhanced Domain Adaptation: A Case Study on Predictive Modeling with Electronic Health Records [57.75125067744978]
  We propose a data augmentation method to facilitate domain adaptation. adversarially generated samples are used during domain adaptation. Results confirm the effectiveness of our method and the generality on different tasks.
  arXiv  Detail & Related papers  (2021-01-13T03:20:20Z)
• Modeling Shared Responses in Neuroimaging Studies through MultiView ICA [94.31804763196116]
  Group studies involving large cohorts of subjects are important to draw general conclusions about brain functional organization. We propose a novel MultiView Independent Component Analysis model for group studies, where data from each subject are modeled as a linear combination of shared independent sources plus noise. We demonstrate the usefulness of our approach first on fMRI data, where our model demonstrates improved sensitivity in identifying common sources among subjects.
  arXiv  Detail & Related papers  (2020-06-11T17:29:53Z)
• Attention-based Neural Bag-of-Features Learning for Sequence Data [143.62294358378128]
  2D-Attention (2DA) is a generic attention formulation for sequence data. The proposed attention module is incorporated into the recently proposed Neural Bag of Feature (NBoF) model to enhance its learning capacity. Our empirical analysis shows that the proposed attention formulations can not only improve performances of NBoF models but also make them resilient to noisy data.
  arXiv  Detail & Related papers  (2020-05-25T17:51:54Z)
• Ensemble Transfer Learning for the Prediction of Anti-Cancer Drug Response [49.86828302591469]
  In this paper, we apply transfer learning to the prediction of anti-cancer drug response. We apply the classic transfer learning framework that trains a prediction model on the source dataset and refines it on the target dataset. The ensemble transfer learning pipeline is implemented using LightGBM and two deep neural network (DNN) models with different architectures.
  arXiv  Detail & Related papers  (2020-05-13T20:29:48Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.